Sunday, April 25, 2010
IOM to Advise FDA on Post-Marketing Drug Safety Trials
The Institute of Medicine has been called upon to advise the FDA regarding post-marketing drug safety trials. George Conk at Otherwise has the details.
--CJR
https://lawprofessors.typepad.com/tortsprof/2010/04/iom-to-advise-fda-on-postmarketing-drug-safety-trials.html
